138 related articles for article (PubMed ID: 38871437)
1. Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force.
Fleurence RL; Kent S; Adamson B; Tcheng J; Balicer R; Ross JS; Haynes K; Muller P; Campbell J; Bouée-Benhamiche E; García Martí S; Ramsey S
Value Health; 2024 Jun; 27(6):692-701. PubMed ID: 38871437
[TBL] [Abstract][Full Text] [Related]
2. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
[TBL] [Abstract][Full Text] [Related]
3. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.
Oortwijn W; Husereau D; Abelson J; Barasa E; Bayani DD; Canuto Santos V; Culyer A; Facey K; Grainger D; Kieslich K; Ollendorf D; Pichon-Riviere A; Sandman L; Strammiello V; Teerawattananon Y
Value Health; 2022 Jun; 25(6):869-886. PubMed ID: 35667778
[TBL] [Abstract][Full Text] [Related]
4. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.
Oortwijn W; Husereau D; Abelson J; Barasa E; Bayani DD; Santos VC; Culyer A; Facey K; Grainger D; Kieslich K; Ollendorf D; Pichon-Riviere A; Sandman L; Strammiello V; Teerawattananon Y
Int J Technol Assess Health Care; 2022 Jun; 38(1):e37. PubMed ID: 35656641
[TBL] [Abstract][Full Text] [Related]
5. Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force.
Marsh K; IJzerman M; Thokala P; Baltussen R; Boysen M; Kaló Z; Lönngren T; Mussen F; Peacock S; Watkins J; Devlin N;
Value Health; 2016; 19(2):125-37. PubMed ID: 27021745
[TBL] [Abstract][Full Text] [Related]
6. Good Practices for Real-World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making.
Berger ML; Sox H; Willke RJ; Brixner DL; Eichler HG; Goettsch W; Madigan D; Makady A; Schneeweiss S; Tarricone R; Wang SV; Watkins J; Mullins CD
Value Health; 2017 Sep; 20(8):1003-1008. PubMed ID: 28964430
[TBL] [Abstract][Full Text] [Related]
7. Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report.
Malone DC; Ramsey SD; Patrick DL; Johnson FR; Mullins CD; Roberts MS; Willke RJ; Marshall DA
Value Health; 2020 Apr; 23(4):409-415. PubMed ID: 32327155
[TBL] [Abstract][Full Text] [Related]
8. Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making.
Berger ML; Sox H; Willke RJ; Brixner DL; Eichler HG; Goettsch W; Madigan D; Makady A; Schneeweiss S; Tarricone R; Wang SV; Watkins J; Daniel Mullins C
Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1033-1039. PubMed ID: 28913966
[TBL] [Abstract][Full Text] [Related]
9. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
Coons SJ; Gwaltney CJ; Hays RD; Lundy JJ; Sloan JA; Revicki DA; Lenderking WR; Cella D; Basch E;
Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250
[TBL] [Abstract][Full Text] [Related]
10. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
[TBL] [Abstract][Full Text] [Related]
11. HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force.
Wang SV; Pottegård A; Crown W; Arlett P; Ashcroft DM; Benchimol EI; Berger ML; Crane G; Goettsch W; Hua W; Kabadi S; Kern DM; Kurz X; Langan S; Nonaka T; Orsini L; Perez-Gutthann S; Pinheiro S; Pratt N; Schneeweiss S; Toussi M; Williams RJ
Value Health; 2022 Oct; 25(10):1663-1672. PubMed ID: 36241338
[TBL] [Abstract][Full Text] [Related]
12. HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.
Wang SV; Pottegård A; Crown W; Arlett P; Ashcroft DM; Benchimol EI; Berger ML; Crane G; Goettsch W; Hua W; Kabadi S; Kern DM; Kurz X; Langan S; Nonaka T; Orsini L; Perez-Gutthann S; Pinheiro S; Pratt N; Schneeweiss S; Toussi M; Williams RJ
Pharmacoepidemiol Drug Saf; 2023 Jan; 32(1):44-55. PubMed ID: 36215113
[TBL] [Abstract][Full Text] [Related]
13. Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report.
Brazier J; Ara R; Azzabi I; Busschbach J; Chevrou-Séverac H; Crawford B; Cruz L; Karnon J; Lloyd A; Paisley S; Pickard AS
Value Health; 2019 Mar; 22(3):267-275. PubMed ID: 30832964
[TBL] [Abstract][Full Text] [Related]
14. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
[TBL] [Abstract][Full Text] [Related]
15. Development and Evaluation of the Algorithm CErtaInty Tool (ACE-IT) to Assess Electronic Medical Record and Claims-based Algorithms' Fit for Purpose for Safety Outcomes.
Singh S; Beyrer J; Zhou X; Swerdel J; Harvey RA; Hornbuckle K; Russo L; Ghauri K; Abi-Elias IH; Cox JS; Rodriguez-Watson C
Drug Saf; 2023 Jan; 46(1):87-97. PubMed ID: 36396894
[TBL] [Abstract][Full Text] [Related]
16. Repeat: a framework to assess empirical reproducibility in biomedical research.
McIntosh LD; Juehne A; Vitale CRH; Liu X; Alcoser R; Lukas JC; Evanoff B
BMC Med Res Methodol; 2017 Sep; 17(1):143. PubMed ID: 28923006
[TBL] [Abstract][Full Text] [Related]
17. Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures: A Good Practices Report of an ISPOR Task Force.
O'Donohoe P; Reasner DS; Kovacs SM; Byrom B; Eremenco S; Barsdorf AI; Arnera V; Coons SJ
Value Health; 2023 May; 26(5):623-633. PubMed ID: 37121630
[TBL] [Abstract][Full Text] [Related]
18. Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA.
Kristensen FB; Husereau D; Huić M; Drummond M; Berger ML; Bond K; Augustovski F; Booth A; Bridges JFP; Grimshaw J; IJzerman MJ; Jonsson E; Ollendorf DA; Rüther A; Siebert U; Sharma J; Wailoo A
Value Health; 2019 Jan; 22(1):13-20. PubMed ID: 30661627
[TBL] [Abstract][Full Text] [Related]
19. A questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report.
Berger ML; Martin BC; Husereau D; Worley K; Allen JD; Yang W; Quon NC; Mullins CD; Kahler KH; Crown W
Value Health; 2014 Mar; 17(2):143-56. PubMed ID: 24636373
[TBL] [Abstract][Full Text] [Related]
20. Health technology assessment in Australia: a role for clinical registries?
Scott AM
Aust Health Rev; 2017 Mar; 41(1):19-25. PubMed ID: 27028134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
